SCHEMBL6313739

SCHEMBL6313739

CCC(Cc1c(C)c(C#N)c2[nH]c3ccccc3n2c1=O)OC(C)=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 15/20 0.64
GAA P10253 11/20 0.64
MAPT P10636 10/20 0.64
ALDH1A1 P00352 9/20 0.64
HPGD P15428 7/20 0.64
KMT2A Q03164 7/20 0.64
GLA P06280 6/20 0.64
STAT6 P42226 1/20 0.64
HIF1A Q16665 1/20 0.64
APAF1 O14727 3/20 0.63
HTT P42858 4/20 0.63
LMNA P02545 2/20 0.63
NOD2 Q9HC29 1/20 0.63
SMN1; SMN2 Q16637 3/20 0.61
RAB9A P51151 2/20 0.61
NPSR1 Q6W5P4 2/20 0.60
ATM Q13315 1/20 0.60
TDP1 Q9NUW8 2/20 0.53
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6312129 0.86 KDM4E (0.64) KDM4EGAAMAPTALDH1A1HPGD
SCHEMBL6311546 0.84 KDM4E (0.70) KDM4EGAAMAPTALDH1A1HPGD
SCHEMBL6650698 0.81 KDM4E (0.74) KDM4EGAAMAPTALDH1A1HPGD
SCHEMBL6311835 0.80 KDM4E (0.80) KDM4EGAAMAPTALDH1A1HPGD
SCHEMBL6310378 0.79 KDM4E (0.69) KDM4EGAAMAPTALDH1A1HPGD
SCHEMBL6653844 0.79 KDM4E (0.81) KDM4EGAAMAPTALDH1A1HPGD
SCHEMBL6652217 0.78 KDM4E (0.81) KDM4EGAAMAPTALDH1A1HPGD
SCHEMBL6311488 0.78 KDM4E (1.00) KDM4EGAAMAPTALDH1A1HPGD
SCHEMBL6311878 0.76 KDM4E (0.91) KDM4EGAAMAPTALDH1A1HPGD
SCHEMBL6649614 0.76 KDM4E (0.91) KDM4EGAAMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 KDM4E 3360/4885GAA 58/4885MAPT 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.